Patents Assigned to MedGene, Inc.
  • Patent number: 6783699
    Abstract: Europium-containing fluorescent nanoparticles and methods of preparing such nanoparticles are provided. The nanoparticles are comprised of an aluminum oxide framework having a europium activator, a magnesium, calcium, strontium, or barium energy reservoir, and at least one co-activator selected from the group consisting of scandium, yttrium, and certain lanthanide elements. The nanoparticles may be optionally coated with a silane coating containing reactive functional groups that allow for attachment of the nanoparticle to a desired biological or chemical target molecule. The coated nanoparticles may be used to detect a variety of protein ligand interactions, and may also be used in assays for nucleic acids.
    Type: Grant
    Filed: October 17, 2002
    Date of Patent: August 31, 2004
    Assignee: MedGene, Inc.
    Inventors: Guangjun Li, Hong Wu, Chunyang Liu
  • Publication number: 20040075083
    Abstract: Europium-containing fluorescent nanoparticles and methods of preparing such nanoparticles are provided. The nanoparticles are comprised of an aluminum oxide framework having a europium activator, a magnesium, calcium, strontium, or barium energy reservoir, and at least one co-activator selected from the group consisting of scandium, yttrium, and certain lanthanide elements. The nanoparticles may be optionally coated with a silane coating containing reactive functional groups that allow for attachment of the nanoparticle to a desired biological or chemical target molecule. The coated nanoparticles may be used to detect a variety of protein ligand interactions, and may also be used in assays for nucleic acids.
    Type: Application
    Filed: October 17, 2002
    Publication date: April 22, 2004
    Applicant: Medgene, Inc.
    Inventors: Guangjun Li, Hong Wu, Chunyang Liu